Ozempic maker Novo Nordisk nudges higher profit forecast

• Novo Nordisk shares jump 8% after Wegovy sales beat expectations

  Business - CNBC - 5 hours ago

• The Novo Nordisk scientist behind Ozempic, Wegovy weight loss research

  Top stories - CBS News - 2 days ago

• Novo Nordisk asks FDA to ban compounding pharmacies from making Ozempic, Wegovy copies

  Business - CNBC - October 23
• 

  Novo Nordisk asks FDA to block compounding pharmacies from making Ozempic copycats

  Politics - The Hill - October 23

• Novo Nordisk's diabetes drug Ozempic may reduce the risk of Alzheimer's disease, study says

  Business - CNBC - October 24

• Novo Nordisk's Ozempic and Wegovy now available in the U.S. after shortages, FDA says

  Business - CNBC - 6 days ago

• With Novo Nordisk success, is there a "Nokia risk" for Denmark?

  Top stories - CBS News - 2 days ago

• Novo Nordisk's Wegovy Sales Beat Expectations

  Business - The Wall Street Journal - 7 hours ago

More from MarketWatch

• Stock futures surge and these areas ‘likely market winners’ as Republicans may sweep

  Business - MarketWatch - 25 minutes ago

• Oil prices retreat after Trump win sends dollar soaring

  Business - MarketWatch - 46 minutes ago

• ‘It strikes me as vengeful’: My friend wants to boycott a coffee shop because of the owner’s political views. Is this what America has become?

  Business - MarketWatch - 1 hour ago

• ‘They were users and abusers’: I cut off friends who borrowed money from me. It cost me $120K in unpaid debts. Was I wrong?

  Business - MarketWatch - 1 hour ago

• What the Trump win means for the mega-cap tech giants, according to this high-profile analyst

  Business - MarketWatch - 1 hour ago